Kyasanur Forest Disease

06/01/2024 - "In this study, we characterised recombinant NS2B-NS3 proteases from ten flaviviruses including three unreported proteases from the Usutu, Kyasanur forest disease and Powassan viruses. "

01/01/2024 - "Tick and tick-borne diseases (TBDs) are increasing annually, and the study of ticks has gained importance after the outbreak of Kyasanur Forest disease (KFD) in the South Western Ghats of India. "

01/01/2023 - "Single-dose VSV-based vaccine protects against Kyasanur Forest disease in nonhuman primates."
01/01/2013 - "Coverage and effectiveness of Kyasanur forest disease (KFD) vaccine in Karnataka, South India, 2005-10."
06/01/1969 - "Serological response in humans to a formolized Kyasanur Forest disease vaccine."
01/01/1967 - "Experimental vaccine against Kyasanur Forest disease (KFD) virus from tissue culture source. "
01/01/1967 - "Experimental vaccine against Kyasanur Forest disease (KFD) virus from tissue culture source. "

06/30/2023 - "We evaluated the safety and potency of the Kyasanur Forest disease (KFD) vaccine inactivated with different formalin concentrations in mice, since the side effects due to higher formalin concentrations have been a major reason for vaccine refusal. "
04/01/1994 - "A formalin inactivated Kyasanur forest disease (KFD) virus tissue culture vaccine produced by the health department of the State Government of Karnataka at Shimoga was administered in Shimoga, Uttar Kannada and Chikmangalur districts during 1990-92 KFD epidemic seasons. "
03/01/1962 - "The administration of formalin-inactivated RSSE virus vaccine in the Kyasanur Forest disease area of Shimoga District, Mysore State."
03/01/1962 - "Evaluation of the field experience with formalin-inactivated mouse brain vaccine of Russian spring-summer encephalitis virus against Kyasanur Forest disease."
06/30/2023 - "Evaluation of Safety and Potency of Kyasanur Forest Disease (KFD) Vaccine Inactivated with Different Concentrations of Formalin and Comparative Evaluation of In Vitro and In Vivo Methods of Virus Titration in KFD Vaccine."

12/01/2012 - "Diagnosis of Kyasanur forest disease by nested RT-PCR, real-time RT-PCR and IgM capture ELISA."
01/01/2022 - "The sensitivity, specificity, and cross-reactivity of the assays were evaluated using NiV IgM, IgG positive, negative human sera and measles, mumps, rubella, Crimean-Congo haemorrhagic fever, Kyasanur forest disease IgM, IgG positive sera, respectively. "
01/01/2019 - "Kinetics of viral RNA, immunoglobulin-M & G antibodies in Kyasanur forest disease."

10/01/1965 - "Demonstration of antibodies against the virus of Kyasanur Forest disease (KFD) in the frugivorous bat Rousettus leschenaulti, near Poona, India."
01/01/2021 - "These antibodies also neutralized other tick-borne flaviviruses, including Langat, louping ill, Omsk hemorrhagic fever, Kyasanur forest disease, and Powassan viruses. "
01/01/2019 - "Kinetics of viral RNA, immunoglobulin-M & G antibodies in Kyasanur forest disease."

01/01/2022 - "Kyasanur forest disease viral RNA was detected from the genera Haemaphysalis and Amblyomma. "
01/01/2019 - "Kinetics of viral RNA, immunoglobulin-M & G antibodies in Kyasanur forest disease."

01/01/2023 - "Kyasanur forest disease is a neglected zoonotic disease caused by a single-stranded RNA-based flavivirus, the incidence of which was first recorded in 1957 in the Southern part of India. "
01/01/2022 - "In Kyasanur Forest disease infection, the blood has more RNA copies/ml than other body fluids, and viremia may last up to two weeks post-infection."

01/01/2024 - "We illustrate the role of land use legacies, trade-offs in land-use decisions, and social inequities in access to land resources, information and decision-making, with three cases: Kyasanur Forest disease in India, Lyme disease in the Outer Hebrides (Scotland), and tick acaricide resistance in cattle in Ecuador. "

07/01/1991 - "Circulating interferon-alpha in patients with Kyasanur forest disease."

01/01/2023 - "These initial findings can potentially facilitate the discovery and development of targeted therapies for treating Kyasanur forest disease."